Publications by authors named "Rose Mantel"

Claim this Profile
E
Eμ-TCL1xMyc: A Novel Mouse Model for Concurrent CLL and B-Cell Lymphoma.
Fabienne Lucas, Kerry A Rogers, Bonnie K Harrington, Alexander Pan, Lianbo Yu, Rose Mantel

Clin Cancer Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation.
Sean D Reiff, Rose Mantel, Lisa L Smith, J T Greene, Elizabeth M Muhowski

Cancer Discov· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noncovalent inhibition of C481S Bruton tyrosine kinase by GDC-0853: a new treatment strategy for ibrutinib-resistant CLL.
Sean D Reiff, Elizabeth M Muhowski, Daphne Guinn, Amy Lehman, Catherine A Fabian, Rose Mantel

Blood· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Bruton Tyrosine Kinase (BTK) Inhibitor Acalabrutinib Demonstrates Potent On-Target Effects and Efficacy in Two Mouse Models of Chronic Lymphocytic Leukemia.
Sarah E M Herman, Arnau Montraveta, Carsten U Niemann, Helena Mora-Jensen, Michael Gulrajani, Rose Mantel

Clin Cancer Res· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel in-frame deletions result in aberrant RNA splicing in CLL patients.
Anant A Agrawal, Michael Seiler, Lindsey T Brinton, Rose Mantel, Rosa Lapalombella

Blood Adv· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BTK-Mediated Resistance to Ibrutinib in Chronic Lymphocytic Leukemia.
Jennifer A Woyach, Amy S Ruppert, Daphne Guinn, Amy Lehman, James S Blachly, Rose Mantel

J Clin Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting BTK through microRNA in chronic lymphocytic leukemia.
Arianna Bottoni, Lara Rizzotto, Tzung-Huei Lai, Chaomei Liu, Lisa L Smith, Rose Mantel

Blood· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia.
Zachary A Hing, Rose Mantel, Kyle A Beckwith, Daphne Guinn, Erich Williams

Blood· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia.
Kami J Maddocks, Amy S Ruppert, Gerard Lozanski, Nyla A Heerema, Weiqiang Zhao, Rose Mantel

JAMA Oncol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged lymphocytosis during ibrutinib therapy is associated with distinct molecular characteristics and does not indicate a suboptimal response to therapy.
Jennifer A Woyach, Kelly Smucker, Lisa L Smith, Arletta Lozanski, Yiming Zhong, Rose Mantel

Blood· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis